CureDuchenne Ventures LLC Provides $1 Million to MyoTherix to Advance Promising Research to Treat Duchenne Muscular Dystrophy.
BEACH, Calif., September 1, 2015 – CureDuchenne Ventures LLC, a company that
funds research to find a cure for Duchenne muscular dystrophy, announced today
that they have invested $1 million in MyoTherix Inc., a biotechnology company
focused on developing novel therapeutics for the treatment of Duchenne and
other muscular dystrophies. The funds will support the Company’s preclinical
studies in mouse models of Duchenne muscular dystrophy as well as preclinical
[Click for more information]